Abu Dhabi Introduces Groundbreaking Blood Test for Early Detection of Multiple Cancers
Abu Dhabi has launched a revolutionary advancement in preventive healthcare: the Trucheck™ intelli blood test, capable of detecting over 70 types of cancer at early stages, often before symptoms appear. This non-invasive test marks a significant leap in oncology screening for the emirate.
A Game-Changer in Early Detection
Unlike traditional screenings that target specific organs, Trucheck™ intelli offers a comprehensive solution through a simple blood draw with no preparation required. It addresses key barriers like fear of invasive procedures and limited awareness, encouraging broader participation in proactive health checks.
Key Features and Limitations
Broad Detection: Screens for numerous cancers, including hard-to-detect types like pancreatic, gastric, and brain cancers.
High Accuracy: Reported accuracy of 95-98%, with a low false-positive rate (~1%).
Limitation: It does not detect blood cancers like leukemia and lymphoma, which require different diagnostic methods.
Cost: Priced between AED 7,000 – 8,000 per annual test. Experts suggest it could be cost-effective compared to multiple individual screenings over time.
Target Audience and Availability
The Abu Dhabi Department of Health has prioritized the initial rollout for Emirati citizens aged 40 and above, a demographic at higher cancer risk due to age. This makes Abu Dhabi a global pioneer in integrating such multi-cancer early detection into public health strategy.
A Complementary Tool, Not a Replacement
Leading oncologists, including Prof. Humaid Al Shamsi, CEO of Burjeel Cancer Institute, emphasize that Trucheck™ intelli is a powerful complement to—not a replacement for—established screenings like mammograms, colonoscopies, and PSA tests. The combined approach offers the best chance for early intervention and reduced cancer mortality.
Also Read: Dubai Metro Expansion: RTA & Emaar Sign Deal to Upgrade Burj Khalifa/Dubai Mall Station
A Paradigm Shift in Preventive Medicine
The introduction of Trucheck™ intelli signifies a major shift towards precision and preventive healthcare. By identifying cancers earlier, Abu Dhabi aims to improve treatment outcomes, survival rates, and reduce the overall disease burden.
As this technology gains adoption, Abu Dhabi’s experience could serve as a global model for integrating advanced, accessible cancer diagnostics into routine healthcare, setting a new standard in the fight against cancer.
